Dr. Briscoe-Dwyer previously served as the chair of the ASHP committee on nominations, council on public policy, and the FASHP recognition committee, according to an Aug. 3 news release. She was also a New York delegate to the ASHP House of Delegates for more than a decade and used to be president of the Long Island Society of Health-System Pharmacists.
Three other ASHP members were elected to the organization’s board of directors. Kristi Gullickson, PharmD, the pharmacy director of Minneapolis-based Abbott Northwestern Hospital, joined the board Aug. 3.
Dawn Moore, PharmD, vice president and chief pharmacy officer of Indianapolis-based Community Health Network, and Douglas Slain, PharmD, chair of the clinical pharmacy department at Morgantown-based West Virginia University, will join the board in June 2024 for their three-year terms.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.